seventy-eight patients with acute nonlymphoblastic leukemia in relapse were treated with high-dose cytosine arabinoside ( 3 g/m2 intravenously ( iv ) every 12 hours for 12 doses ) alone , or with three days of anthracycline antibiotics ( doxorubicin 20 mg/m2 or daunorubicin 30 mg/m2 iv daily ) after completing the course of cytosine arabinoside .
C0023467
acute nonlymphoblastic leukemia
C0011015
daunorubicin